glp-1 neuroinflammation Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment The anti-inflammatory and immunological properties

2 AminianA.ZajichekA.TuC.WolskiK

In addition to emphasizing traditional strategies such as healthy eating, physical activity, and behavioral support, the new guidelines now encourage physicians to consider prescribing GLP-1 receptor agonistssuch as Ozempic and Wegovyto children as young as 12

Following recurrent treatment with the GLP-1R agonist liraglutide (CM + Lira), we observed a significant decrease in the expression of PI3K (0.68 0.05 vs

Erythritol and xylitol play significant roles in the secretion of GLP-1, CCK, and PYY, while also reducing ghrelin levels

Moreover, GLP-1 exerts stabilizing effects on the endothelial contraction and barrier for AGE-treated endothelium via activating GLP-1R/cyclic adenosine monophosphate (cAMP)/PKA and inhibiting mitogen-activated protein kinase (MAPK) signaling pathways together with RAGE/Rho/ROCK [97, 98]